Skip to main content
Equibles

ASSETMARK, INC

Position in GMAB — Genmab A/S

CIK 1344551 CONCORD, CA
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$6,559,918
+$546,135 QoQ
Shares Held
238,803
+6.5% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#42
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ASSETMARK, INC holds $347,870,603 across 93 Biotechnology names. GMAB ranks #9 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 3,433,824 $186,834,363
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 61,055 $30,327,850
3 DFTX
Definium Therapeutics, Inc.
 396,542 $18,653,335
4 HALO
Halozyme Therapeutics, Inc.
 174,334 $13,645,122
5 PTGX
Protagonist Therapeutics, Inc
 98,687 $12,097,052
6 ONC
BeOne Medicines Ltd.
 32,399 $9,232,743
7 REGN
Regeneron Pharmaceuticals, Inc.
 12,594 $7,852,862
8 ARGX
Argenx SE
 7,699 $7,142,901

All Filings in GMAB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,559,918 238,803
2026-03-31 $6,013,783 224,144
2025-12-31 $7,202,641 233,852
2025-09-30 $284,188 9,266
2025-06-30 $4,462 216
2025-03-31 $4,268 218
2024-12-31 $377,934 18,109
2024-09-30 $2,014,495 82,629
2024-06-30 $1,786,994 71,110
2024-03-31 $1,950,879 65,225
2023-12-31 $1,385,613 43,518
2023-09-30 $1,441,908 40,882
2023-06-30 $1,401,086 36,861
2023-03-31 $1,106,556 29,305
2022-12-31 $1,058,949 24,987
2022-09-30 $814,752 25,358
2022-06-30 $629,168 19,365
2022-03-31 $458,545 12,674
2021-12-31 $335,508 8,481
2021-09-30 $2,099,959 48,054
2021-06-30 $1,788,354 43,800
2021-03-31 $961,065 29,274
2020-12-31 $1,091,639 26,848
2020-09-30 $675,930 18,463
2020-06-30 $107,126 3,161
2020-03-31 $85,226 4,022